These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27053957)

  • 1. C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome.
    Xu YP; Lin G; Sun XJ; Yan MH; Zhang G; Hu JL; Sun WY; Yu JM
    J Cancer; 2016; 7(5):587-94. PubMed ID: 27053957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
    Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
    Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma.
    Xu Y; Peng Z; Li Z; Lu M; Gao J; Li Y; Li Y; Shen L
    BMC Cancer; 2015 Jan; 15():6. PubMed ID: 25588551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer.
    Guo K; Wang WP; Jiang T; Wang JZ; Chen Z; Li Y; Zhou YA; Li XF; Lu Q; Zhang LJ
    J Thorac Dis; 2016 Jul; 8(7):1753-63. PubMed ID: 27499966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance.
    Jia W; Wang W; Ji CS; Niu JY; Lv YJ; Zhou HC; Hu B
    Onco Targets Ther; 2016; 9():5133-42. PubMed ID: 27574454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma.
    Wang H; Jiang D; Song Q; Xu C; Shi Y; Li X; Huang J; Xu Y; Sujie A; Zeng H; Zhong Y; Tan L; Hou Y
    Tumour Biol; 2016 Jul; 37(7):9771-9. PubMed ID: 26810066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
    Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
    Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.
    Petrini I; Lencioni M; Vasile E; Fornaro L; Belluomini L; Pasquini G; Ginocchi L; Caparello C; Musettini G; Vivaldi C; Caponi S; Ricci S; Proietti A; Fontanini G; Naccarato AG; Nardini V; Santi S; Falcone A
    Cancer Biomark; 2018 Feb; 21(3):731-741. PubMed ID: 29278885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma.
    Lin G; Sun XJ; Han QB; Wang Z; Xu YP; Gu JL; Wu W; Zhang GU; Hu JL; Sun WY; Mao WM
    Oncol Lett; 2015 Aug; 10(2):901-906. PubMed ID: 26622592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
    Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
    Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression levels of HER2 and MRP1 are not prognostic factors of long-term survival in 829 patients with esophageal squamous cell carcinoma.
    Chen Y; Zhu SM; Xu XL; Zhao AN; Hu JL
    Oncol Lett; 2016 Jan; 11(1):745-752. PubMed ID: 26870278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of P-EGFR and P-Akt protein in esophageal squamous cell carcinoma and its prognosis.
    Shan ZZ; Chen PN; Wang F; Wang J; Fan QX
    Oncol Lett; 2017 Sep; 14(3):2859-2863. PubMed ID: 28927043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of c-Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma.
    Jiang M; Zhang H; Xiao H; Zhang Z; Que D; Luo J; Li J; Mao B; Chen Y; Lan M; Wang G; Xiao H
    Oncol Lett; 2018 Jan; 15(1):931-939. PubMed ID: 29391895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
    Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
    Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
    Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR Expression in Patients with Esophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran.
    Anvari K; Sima HR; Seilanian Toussi M; Anvari A; Shahidsales S; Memar B; Aledavoud SA; Forghani MN; Abdollahi A; Ghaffarzadegan K
    Arch Iran Med; 2017 Apr; 20(4):240-245. PubMed ID: 28412829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.